Amgen to buy Turkish firm in $700M deal
Thousand Oaks-based Amgen said it will acquire Mustafa Nevzat Pharmaceuticals, a major supplier of pharmaceuticals and injectable medicines in Turkey, in a deal that values the Turkish firm at $700 million. Amgen said that its focus on Turkey and the surrounding region is part of a broad international expansion strategy for the company. Amgen established Read More →
Read More →NiMin Energy to dissolve
NiMin Energy, a small independent oil and gas firm based in Caprinteria, is selling its Wyoming assets for $98 million and dissolving itself. The company, which is traded on the Toronto Stock Exchange, is also in talks to sell its San Joaquin Valley assets in California. The company said the money will be used to Read More →
Read More →Teledyne’s profits rise in Q1
Thousand Oaks-based Teledyne Technologies beat Wall Street’s expectations on April 25 when it reported first-quarter profits of $35.7 million on $494 million in sales. The profits work out to 96 cents a share, well above the 91-cent average estimate of six analysts, according to data from Thomson Reuters. Sales were 5.5 percent above the same Read More →
Read More →Inphi loses $1.5M in Q1
Nearly three months after Inphi. Corp. hired a new CEO to recover from a 93 percent drop in profits in 2011, the semiconductor company reported a net loss of $1.5 million for the first quarter. The Santa Clara-based company, which designs chips aimed at packing more memory onto Internet servers and increasing bandwidth, employs a Read More →
Read More →Amgen revenue up 9 percent
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”24-10-2011″ enddate=”24-04-2012″ width=”300″ height=”245″] Amgen’s total revenue shot up 9 percent during the first quarter of this year, the Thousand Oaks-based biotech giant said in an April 24 earnings report. The biotech company reported revenue of $4 billion, up from $3.7 billion in the first quarter of 2011. Total product Read More →
Read More →Regulators scrutinize Community West
Community West Bancshares faces a new order from regulators that limits its ability to pay out dividends, sell stock or incur new debts without the prior approval of the federal banking overseers. The parent of Community West Bank also agreed with the Federal Reserve Bank of San Francisco on April 23 that the Goleta firm Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
